Compare ATRC & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | ICHR |
|---|---|---|
| Founded | 2000 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2005 | 2016 |
| Metric | ATRC | ICHR |
|---|---|---|
| Price | $29.02 | $48.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $51.17 | $45.67 |
| AVG Volume (30 Days) | 493.0K | ★ 586.9K |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.74 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $201,630,000.00 | ★ $947,652,000.00 |
| Revenue This Year | $15.27 | $19.98 |
| Revenue Next Year | $12.21 | $15.92 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.40 | 11.61 |
| 52 Week Low | $27.31 | $13.15 |
| 52 Week High | $43.18 | $55.00 |
| Indicator | ATRC | ICHR |
|---|---|---|
| Relative Strength Index (RSI) | 42.11 | 54.59 |
| Support Level | $28.60 | $15.74 |
| Resistance Level | $30.90 | $53.95 |
| Average True Range (ATR) | 1.13 | 3.92 |
| MACD | 0.14 | -0.31 |
| Stochastic Oscillator | 46.11 | 57.77 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries. Its product portfolio includes gas and chemical delivery subsystems that enable precise delivery, monitoring, and control of specialized gases and reactive liquid chemistries used in semiconductor manufacturing processes such as etch, electroplating, and cleaning. The company also provides precision-machined components, weldments, e-beam and laser-welded components, as well as precision vacuum and hydrogen brazing. Geographically, the company operates across the United States, Singapore, Europe, and other regions, with Singapore contributing the majority of revenue.